#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage III Leukoencephalopathy Retinitis pigmentosa Rhabdoid tumour Acute myeloid leukaemia (in remission) Insulinoma Prophylaxis against transplant rejection Medulloblastoma Thalassaemia Liposarcoma recurrent Leukaemia Tourette's disorder Squamous cell carcinoma of the hypopharynx Blood iron increased Neuroendocrine cell hyperplasia of infancy More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma refractory – Treatment Burkitt’s lymphoma Primary biliary cholangitis – Diagnostics Haemophilia B without inhibitors Indolent systemic mastocytosis – Treatment Pelizaeus-Merzbacher disease Atypical teratoid/rhabdoid tumour of CNS Haemolytic uraemic syndrome – Treatment MELAS syndrome – Treatment Myelodysplastic syndrome with excess blasts – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Diltiazem Hydrochloride Gsk4004280 Myrrh Potato Starch GSKVX000000070248 X-396 Albiglutide Zinc Oxide Botaretigene Sparoparvovec Desogestrel GS-4321 MAGNESIUM ACETATE TETRAHYDRATE Ima402 Thalidomide Sodium Valproate Ceralasertib Moxifloxacin Hydrochloride Eribulin Mesylate Jnj-77242113 Methyl Aminolevulinate More therapies…

    Learn about Your Condition

    Narcolepsy Hand fracture Retroperitoneal cancer Trisomy 21 Inner ear disorder Cortical dysplasia Adenomyosis Turner's syndrome Hypothyroidism Actinic keratosis Colon cancer stage IV Nephrogenic anaemia Colon cancer stage II Type 2 diabetes mellitus Mucopolysaccharidosis I More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Premedication with Ketamine or Fentanyl for Patients with Respiratory Distress Syndrome Receiving Surfactant Treatment

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory distress syndrome
    Investigated Drugs:
    • Fentanyl Citrate
    • Esketamine Hydrochloride
    Finland

  • Study on the Safety and Effects of YTB323, Tocilizumab, and Cyclophosphamide in Patients with Relapsing Multiple Sclerosis Who Have Active Disease Despite Treatment

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    France Germany Italy Spain

  • Study on Theophylline, Gadoteric Acid, and Regadenoson for Patients with Chronic Total Coronary Artery Blockage

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic disease
    • Coronary artery occlusion
    Investigated Drugs:
    • THEOPHYLLINE ANHYDROUS
    • Regadenoson
    • Gadoteric Acid
    Spain

  • Study on the Safety of Micronized Progesterone and Norethisterone Acetate with Estradiol for Menopausal Symptoms in Women

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Menopausal symptoms
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    • NORETHISTERONE ACETATE
    Sweden

  • A study comparing epinephrine and isoprenaline in patients with out-of-hospital cardiac arrest who have non-shockable heart rhythm

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Isoprenaline Hydrochloride
    • Epinephrine
    Denmark

  • Study on Sedation Safety and Effectiveness in Bronchoscopy: Comparing Propofol/Pethidine and Midazolam/Pethidine for Patients with Respiratory Conditions

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • PETHIDINE HYDROCHLORIDE
    • Propofol
    Italy
Previous Page
1 … 817 818 819 820 821 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!